Quinagolide

• Description:

  Quinagolide (CV205-502) is a non-ergot dopamine D (2) receptor agonist that promotes dopamine activity. Quinagolide has shown effectiveness in modulating endocrine function, particularly in inhibiting disorders associated with dopamine deficiency. Quinagolide is used to suppress hyperprolactinemia and corresponding clinical symptoms, showing good efficacy. Quinagolide's biological activity enables its use as an important research compound in drug isolation and analysis[1].

• Product Name Alternative:

  CV205-502

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H312-H332

• Target:

  Dopamine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/quinagolide.html

• Smiles:

  OC1=C2C(C[C@](N(CCC)C[C@@H](NS(N(CC)CC)(=O)=O)C3)([H])[C@@]3([H])C2)=CC=C1

• Molecular Formula:

  C20H33N3O3S

• Molecular Weight:

  395.56

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations:

  [1]Chiral Separations by Host-Guest Complexation with Cyclodextrin and Crown Ether in Capillary Zone Electrophoresis

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  [87056-78-8]